| Literature DB >> 35139905 |
Stefan Niemann1,2, Jan Rupp3,4, Matthias Merker5,6,7, Margo Diricks1,2, Thomas A Kohl1,2, Nadja Käding3,4, Vladislav Leshchinskiy3, Susanne Hauswaldt3, Omar Jiménez Vázquez1, Christian Utpatel1,2.
Abstract
BACKGROUND: Bacteria belonging to the genus Haemophilus cause a wide range of diseases in humans. Recently, H. influenzae was classified by the WHO as priority pathogen due to the wide spread of ampicillin resistant strains. However, other Haemophilus spp. are often misclassified as H. influenzae. Therefore, we established an accurate and rapid whole genome sequencing (WGS) based classification and serotyping algorithm and combined it with the detection of resistance genes.Entities:
Keywords: Antibiotic resistance; H. haemolyticus; H. influenzae; Haemophilus; Identification; Molecular differentiation; Pangenome-wide association study; Precision medicine; Whole genome sequencing
Mesh:
Substances:
Year: 2022 PMID: 35139905 PMCID: PMC8830169 DOI: 10.1186/s13073-022-01017-x
Source DB: PubMed Journal: Genome Med ISSN: 1756-994X Impact factor: 11.117
Selected H. influenzae and H. haemolyticus marker genes
| Gene name | Marker for | Average size (bp) | Annotation (protein product) |
|---|---|---|---|
| 1365 | Diaminobutyrate--2-oxoglutarate aminotransferase | ||
| 1659 | Heme/hemopexin transporter protein | ||
| 936 | Oligopeptide transport system permease protein | ||
| 579 | Pyridoxal 5'-phosphate synthase subunit | ||
| 696 | Phosphate regulon transcriptional regulatory protein | ||
| 624 | FKBP-type 22 kDa peptidyl-prolyl cis-trans isomerase | ||
| 1113 | Hydrogenase maturation factor | ||
| 576 | NAD(P)H-quinone oxidoreductase subunit I | ||
| 483 | Thiol-disulfide oxidoreductase | ||
| 522 | 34 kDa membrane antigen |
Fig. 1Presence and absence of marker genes in the training dataset. The phylogenetic tree is based on the alignment of 455 core genes (present in at least 90% of the strains) inferred from 215 whole genome sequencing datasets of human-related Haemophilus spp. A Presence/absence of marker genes that specifically discriminate between H. haemolyticus and H. influenzae. B Presence/Absence of haemin biosynthesis genes (hem*), which are colored according to the species identity of the reference alleles for which a valid hit was found. C Presence/absence of lacZ, a β-galactosidase gene that differentiates between H. parahaemolyticus and H. paraphrohaemolyticus. D Presence/absence of nadV, which is related to the H. ducreyi characteristic V factor independency. E Presence/absence of Region I (bex*), region II and region III (hcs*) capsule loci (in silico serotyping). All annotated Haemophilus spp. clades were separated with a strong local support value (100%)
Fig. 2Decision algorithm to classify human-related strains of Haemophilus spp. based on whole genome sequencing data. The number next to the arrow specifies the minimum number of marker genes that needs to be detected before a (sub)species tag is attributed to the strain
Fig. 3Phylogeny of 262 clinical Haemophilus spp. isolates from a German cohort. The phylogenetic tree is based on the alignment of 104 core genes (present in at least 90% of the strains). A Kraken2 read classification output. The length of a bar is proportional to the percentage of reads that are assigned to the respective taxon (as indicated by the color). One H. influenzae culture (located in the phylogenetic tree in the “fuzzy” clade) was likely contaminated with a Streptococcus sp. strain (19% of the reads assigned to this species) and another one with an Aggregatibacter sp. strain (52% reads assigned to this species). B Presence/absence of marker genes included in our new taxonomic classification database. C Final classification output of the decision algorithm. Mixed colors represent the presence of multiple full marker patterns, indicating multiple distinct Haemophilus species. D Presence/absence of antibiotic resistance genes included in a public resistance database. Color codes correlate to the antibiotic class to which the gene confers resistance: aminoglycosides (Agly), β-lactam antibiotics (Bla), phenicols (Phe), trimethoprim (Tmt), macrolide-lincosamide-streptogramin (MLS), sulfonamides (Sul), and tetracyclines (Tet)